RBC Capital upgrades Gilead Sciences on new leadership optimism

RBC Capital upgraded the biotechnology company from "outperform" to "top pick", citing new leadership. Yahoo Finance's Jared Blikre joins Akiko Fujita on 'The Ticker' to discuss.